Optimizing the Regulatory Strategy for an Anti-cancer Drug
Certara scientists performed helped a small biotech company create a clinical pharmacology package for their NDA submission for a novel oncology drug.
Month: February 2020
Using Modeling and Simulation to Optimize the Timing of Maternal Influenza Vaccination
A M&S model was built to offer an alternate approach to dedicated timing studies to determine the best time to vaccinate pregnant women.
Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.
PRINCETON, NJ – Feb. 25, 2020 – Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc. Acquisition will spur the development of new drugs to treat complex neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease.
Getting started with in-house development: 记事板制作
Introducing our three-part blog series on getting started with in-house development. In this series, we’re detailing some key aspects of how you can create and deploy your own mobile apps, for the purposes of stakeholder engagement and value communication, in-house—without the help of external agencies. Developing mobile apps in-house is increasingly popular compared to outsourced … Continued
罕见病药物困境：价值大、价格高、准入受限？
This webinar will explain how pricing has evolved for the rare disease drug market and best practices for supporting value-based pricing.
Getting started with in-house development: the skills you need
Introducing our three-part blog series on getting started with in-house development. In this series, we’re detailing some key aspects of how you can create and deploy your own mobile apps, for the purposes of stakeholder engagement and value communication, in-house—without the help of external agencies. Developing mobile apps in-house is increasingly popular compared to outsourced … Continued
PK CDISC 数据技术解决方案如何加快您的药物开发
This blog discusses the development of pharmacokinetic CDISC data standards and the impact of building them for electronic regulatory submissions.
Arvinas Selects Certara to Advance Speed and Efficiency of its Targeted Protein Degradation Research
PRINCETON, NJ – Feb. 10, 2020 – Arvinas Selects Certara to Advance Speed and Efficiency of its Targeted Protein Degradation Research
Getting started with in-house development: how does it work?
Introducing our three-part blog series on getting started with in-house development. In this series, we’re detailing some key aspects of how you can create and deploy your own mobile apps, for the purposes of stakeholder engagement and value communication, in-house—without the help of external agencies. Developing mobile apps in-house is increasingly popular compared to outsourced … Continued
1 of 1
